Benefit
Short position disclosed on August 10, 2026.
0.60% of the capital sold short
1 disclosing funds
3 disclosures on record
PLBNFTS00018 ISIN code
Funds holding Benefit Titelia
Evolution of the disclosed total
0%0.2%0.4%0.6%0.8%
Jul 27Jul 31Aug 4Aug 8Aug 12
Open positions
| Fund | Twelve months | % of capital | Over the year | Since |
|---|---|---|---|---|
| Qube Research & Technologies Limited | 0.60% | -0.08 pt | August 10, 2026 |
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| August 10, 2026 | Qube Research & Technologies Limited | 0.60% | still open |
| August 6, 2026 | Qube Research & Technologies Limited | 0.59% | still open |
| July 23, 2026 | Qube Research & Technologies Limited | 0.68% | still open |
Other companies sold short in Poland
- Modivo 4.66% of the capital sold short
- JSW 3.30% of the capital sold short
- Grupaazoty 2.62% of the capital sold short
- Allegro 1.48% of the capital sold short
- Budimex 1.39% of the capital sold short
- Crquantum 1.08% of the capital sold short
- Kety 0.81% of the capital sold short
- Dinopl 0.70% of the capital sold short
- Pepco 0.69% of the capital sold short
- Cdprojekt 0.60% of the capital sold short
- Assecopol 0.59% of the capital sold short
- Scanway 0.51% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Benefit, source KNF, data as at August 10, 2026, https://www.quivad.com/action/benefit